Please login to the form below

Not currently logged in
Email:
Password:

premature ejaculation

This page shows the latest premature ejaculation news and features for those working in and with pharma, biotech and healthcare.

Forest Labs agrees $1.46bn deal to buy Furiex

Forest Labs agrees $1.46bn deal to buy Furiex

as well as Priligy (dapoxetine) for premature ejaculation.

Latest news

  • Menarini launches urology campaign in Greece Menarini launches urology campaign in Greece

    Menarini is supporting a new awareness initiative to educate men about premature ejaculation. ... women's satisfaction during sex, along with a range of information on premature ejaculation.

  • Menarini to raise awareness of sexual dysfunction Menarini to raise awareness of sexual dysfunction

    The new campaign – 'Firing Too Quickly' – is designed to raise awareness of premature ejaculation. ... We are delighted to launch 'Firing Too Quickly' and hope to support men (and their partners) in the management of premature ejaculation," commented

  • EMA backs drugs from Novo, Otsuka, AZ, Janssen, GSK EMA backs drugs from Novo, Otsuka, AZ, Janssen, GSK

    backed for the treatment of primary premature ejaculation in adult men.

  • Pharma deals for May 2012 Pharma deals for May 2012

    Licence. Priligy for premature ejaculation (launched/ P3). 75. Evotec / Zhejiang CONBA Pharmaceutical (b).

  • Race to recovery

    Plethora. Plethora Solutions is in the news as the biotech company announced highly successful results for a final US phase III trial for PSD502, its premature ejaculation spray.

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics